Diferencia entre revisiones de «Template:Cholecystitis Antibiotics»

Sin resumen de edición
Sin resumen de edición
Línea 1: Línea 1:
''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]; pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''
''Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and [[anaerobes]], especially [[Bacteroides fragilis]]; pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections''<ref>Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5</ref>


====Uncomplicated Cholecystitis====
====Uncomplicated Cholecystitis====

Revisión del 02:33 3 abr 2019

Most often isolated organisms are Escherichia coli, Klebsiella pneumonia, and anaerobes, especially Bacteroides fragilis; pathogenicity of Enterococci remains unclear and specific coverage is not routinely suggested for community-acquired infections[1]

Uncomplicated Cholecystitis

Complicated

Complicated disease such as severe sepsis or hemodynamic instability

  • Vancomycin 15-20mg/kg PLUS any of the following options

Options:

  1. Ansaloni L, et al. 2016 WSES guidelines on acute calculous cholecystitis. World Journal of Surgery. (2016) 11:25. DOI 10.1186/s13017-016-0082-5